These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8322165)

  • 21. Attenuation of apoptosis and the eye of the beholder.
    Sobel BE; Zaman T; Budd RC; Schneider DJ; Taatjes DJ
    Coron Artery Dis; 2008 Feb; 19(1):55-8. PubMed ID: 18281817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REVIEW paper: pathophysiology of myocardial reperfusion injury: the role of genetically engineered mouse models.
    Ramachandran A; Jha S; Lefer DJ
    Vet Pathol; 2008 Sep; 45(5):698-706. PubMed ID: 18725477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac stunning in the clinic: the full picture.
    Pomblum VJ; Korbmacher B; Cleveland S; Sunderdiek U; Klocke RC; Schipke JD
    Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):86-91. PubMed ID: 19773228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
    House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J
    Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathophysiology of the "hibernating" myocardium].
    Schulz R; Heusch G
    Z Kardiol; 1995; 84 Suppl 4():91-100. PubMed ID: 8585279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury.
    Elliott GT
    J Mol Cell Cardiol; 1998 Jan; 30(1):3-17. PubMed ID: 9500877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial ischemia and reperfusion injury.
    Buja LM
    Cardiovasc Pathol; 2005; 14(4):170-5. PubMed ID: 16009313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and reperfusion.
    Cain BS; Harken AH; Meldrum DR
    J Mol Cell Cardiol; 1999 May; 31(5):931-47. PubMed ID: 10336835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global ischemic duration and reperfusion function in the isolated perfused rat heart.
    Palmer BS; Hadziahmetovic M; Veci T; Angelos MG
    Resuscitation; 2004 Jul; 62(1):97-106. PubMed ID: 15246589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
    Canyon SJ; Dobson GP
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of transforming growth factor-beta 1 on myocardial stunning in the intact dog.
    Sun JZ; Li XY; Sporn MB; Schneider MD; Roberts R; Bolli R
    J Mol Cell Cardiol; 1993 Apr; 25(4):379-86. PubMed ID: 8340931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardioprotection by anesthetics].
    Hara T
    Masui; 2006 May; 55(5):552-9. PubMed ID: 16715909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathophysiology of myocardial ischemia].
    Baumgart D; Heusch G
    Klin Anasthesiol Intensivther; 1995; 47():3-45. PubMed ID: 7715178
    [No Abstract]   [Full Text] [Related]  

  • 36. PPAR-γ and AMPK--advantageous targets for myocardial ischemia/reperfusion therapy.
    Morrison A; Li J
    Biochem Pharmacol; 2011 Aug; 82(3):195-200. PubMed ID: 21536015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is oxytocin a therapeutic factor for ischemic heart disease?
    Alizadeh AM; Mirzabeglo P
    Peptides; 2013 Jul; 45():66-72. PubMed ID: 23659864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathology of cardiac ischaemia: cellular and molecular aspects.
    Lee JA
    J Pathol; 1995 Feb; 175(2):167-74. PubMed ID: 7738711
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop.
    Kloner RA; Bolli R; Marban E; Reinlib L; Braunwald E
    Circulation; 1998 May; 97(18):1848-67. PubMed ID: 9603540
    [No Abstract]   [Full Text] [Related]  

  • 40. Perfusion-contraction match and mismatch.
    Heusch G; Schulz R
    Basic Res Cardiol; 2001 Feb; 96(1):1-10. PubMed ID: 11215527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.